(Q43698024)

26 November 2017

Lamotrigine therapy of epilepsy in tuberous sclerosis (English)

1 reference

26 November 2017

1 reference

D N Franz

1

1 reference

26 November 2017

C Tudor

2

1 reference

26 November 2017

J Leonard

3

1 reference

26 November 2017

J C Egelhoff

4

1 reference

26 November 2017

A Byars

5

1 reference

26 November 2017

K Valerius

6

1 reference

26 November 2017

G Sethuraman

7

1 reference

26 November 2017

1 July 2001

1 reference

26 November 2017

1 reference

26 November 2017

42

1 reference

26 November 2017

7

1 reference

26 November 2017

935-940

1 reference

Lamotrigine in childhood epilepsies

26 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Diagnosis and management of tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

New developments in the neurobiology of the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Lamotrigine. A review of its use in childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

Mechanisms underlying epileptogenesis in cortical malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.042007935.X

10.1046/J.1528-1157.2001.042007935.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference